Healthcare Shares Lag as Investors Pivot to Growth in a Broad Rally…Update-4 Sideways market with biotechs trading better
Update-4 June 8 Sideways market with trading opportunities in Small cap biotechs. With markets so choppy day to day and volatile within day it is hard to trade. But in my most recent trades I am more hopeful with this buying window. The bellwether remains XBI which at $73 is in the money for...
Large Cap Biopharmaceuticals: Provide Growth, Value and Yield…Update-3
May 25 -Update-3 ..We will take this little rally after all the turmoil recently. Our Strategy has not changed since January which is to stay with large cap biopharma stocks . We would like to pick some winners among the smaller cap biotech and diagnostics stocks but it has been difficult....
Hiding from Volatility with Healthcare Stocks…Update2- oversold rally time!
Update-2 ...5/13 Many analysts see today's sharp upside action as an oversold rally from 2022 lows.The highest risk stocks soared along with large cap tech stocks. NASDAQ was up 3.75%,S&P up 2.3%, DOW up 1.42%. To some extent this shifted action away from more defensive healthcare up only...
How is it going with the Big Biopharma Earnings Week?…Update-5…a wild volatile week!
Update -5 ...5/6 A wild volatile week catalyzed by FED policy statements. We won't go into the debate over FED communications about rate hikes and just say that rising rates are a headwind for equities and curb speculation. With higher rates small cap growth has a higher bar of financial...
Risky Trading Days Lie Ahead, Can Earnings Support the Bulls? Update-4…. broad sell-off
4/26 The constellation of bad news is overwhelming the market: China lock-down, War in Ukraine, commodity prices and WTI up and a horrible tape. MSFT earnings should help us tomorrow but we are in a bear mindset. IBB down 3.86% to $119.39 a 52 week low and the XBI down 5.98% to $76.69 at...